ICPT - Intercept Pharmaceuticals, Inc.
NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Currency in USD
Valuation Measures
| Market Cap (intraday) 5 | 3.52B |
| Enterprise Value 3 | 3.68B |
| Trailing P/E | N/A |
| Forward P/E 1 | -10.40 |
| PEG Ratio (5 yr expected) 1 | 1.30 |
| Price/Sales (ttm) | 15.05 |
| Price/Book (mrq) | 26.91 |
| Enterprise Value/Revenue 3 | 15.72 |
| Enterprise Value/EBITDA 6 | -12.20 |
Trading Information
Stock Price History
| Beta (3Y Monthly) | 1.17 |
| 52-Week Change 3 | 13.01% |
| S&P500 52-Week Change 3 | 18.19% |
| 52 Week High 3 | 131.87 |
| 52 Week Low 3 | 56.76 |
| 50-Day Moving Average 3 | 85.36 |
| 200-Day Moving Average 3 | 74.21 |
Share Statistics
| Avg Vol (3 month) 3 | 556.77k |
| Avg Vol (10 day) 3 | 926.92k |
| Shares Outstanding 5 | 32.73M |
| Float | 25.86M |
| % Held by Insiders 1 | 24.22% |
| % Held by Institutions 1 | 72.67% |
| Shares Short (Nov 15, 2019) 4 | 5.72M |
| Short Ratio (Nov 15, 2019) 4 | 12.21 |
| Short % of Float (Nov 15, 2019) 4 | 31.30% |
| Short % of Shares Outstanding (Nov 15, 2019) 4 | 17.47% |
| Shares Short (prior month Oct 15, 2019) 4 | 5.7M |
Dividends & Splits
| Forward Annual Dividend Rate 4 | N/A |
| Forward Annual Dividend Yield 4 | N/A |
| Trailing Annual Dividend Rate 3 | N/A |
| Trailing Annual Dividend Yield 3 | N/A |
| 5 Year Average Dividend Yield 4 | N/A |
| Payout Ratio 4 | 0.00% |
| Dividend Date 3 | N/A |
| Ex-Dividend Date 4 | N/A |
| Last Split Factor (new per old) 2 | N/A |
| Last Split Date 3 | N/A |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | Dec 31, 2018 |
| Most Recent Quarter (mrq) | Sep 30, 2019 |
Profitability
| Profit Margin | -143.09% |
| Operating Margin (ttm) | -130.51% |
Management Effectiveness
| Return on Assets (ttm) | -28.06% |
| Return on Equity (ttm) | -295.33% |
Income Statement
| Revenue (ttm) | 233.78M |
| Revenue Per Share (ttm) | 7.57 |
| Quarterly Revenue Growth (yoy) | 31.80% |
| Gross Profit (ttm) | 177.28M |
| EBITDA | -301.24M |
| Net Income Avi to Common (ttm) | -334.53M |
| Diluted EPS (ttm) | -10.83 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 712.37M |
| Total Cash Per Share (mrq) | 21.76 |
| Total Debt (mrq) | 537.58M |
| Total Debt/Equity (mrq) | 411.20 |
| Current Ratio (mrq) | 5.49 |
| Book Value Per Share (mrq) | 3.99 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -228.94M |
| Levered Free Cash Flow (ttm) | -107.92M |